Research paperDouble-blind, placebo-controlled trial of Pioglitazone (cas 111025-46-8) for bipolar depression
-
Add time:08/27/2019 Source:sciencedirect.com
BackgroundObjective of the present study was to conduct an 8-week double-blind, randomized, placebo-controlled trial to test the efficacy of Pioglitazone (cas 111025-46-8) in the treatment of bipolar depression.
We also recommend Trading Suppliers and Manufacturers of Pioglitazone (cas 111025-46-8). Pls Click Website Link as below: cas 111025-46-8 suppliers
Prev:Pioglitazone (cas 111025-46-8) suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ
Next:Original ArticleNanoemulsion strategy of Pioglitazone (cas 111025-46-8) for the treatment of skin inflammatory diseases) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ArticlePreparation of polymer microspheres capable for Pioglitazone (cas 111025-46-8) release to modify macrophages function08/30/2019
- Original articlePPAR-γ agonist Pioglitazone (cas 111025-46-8) reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease08/29/2019
- Original ArticleNanoemulsion strategy of Pioglitazone (cas 111025-46-8) for the treatment of skin inflammatory diseases08/28/2019
- Pioglitazone (cas 111025-46-8) suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ08/26/2019
- Effect of oral administration of Pioglitazone (cas 111025-46-8) on follicular dynamics in Holstein dairy cows08/25/2019
- Pioglitazone (cas 111025-46-8) as an adjuvant of amphotericin B for the treatment of cryptococcosis08/24/2019
- Pioglitazone (cas 111025-46-8) attenuates kidney fibrosis via miR-21-5p modulation08/23/2019
- Adiponectin is required for Pioglitazone (cas 111025-46-8)-induced improvements in hepatic steatosis in mice fed a high-fat diet08/22/2019
-
Health and Chemical more >